Spectrum pharmaceuticals inc (SPPI)
Balance Sheet / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Dec'10
ASSETS
Current assets:
Cash and cash equivalents

70,352

64,418

124,598

118,251

272,652

157,480

166,541

174,371

183,513

227,323

247,468

138,313

137,196

158,222

171,605

155,759

132,306

139,741

136,527

142,271

123,365

129,942

144,234

132,405

117,734

156,306

71,974

121,103

160,073

139,698

143,283

190,154

149,373

121,202

110,293

67,049

53,557

Restricted Cash

-

-

4,040

4,020

4,000

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Marketable securities

107,441

159,455

123,164

160,134

33,229

46,508

54,014

95,287

48,403

248

248

248

247

247

247

247

246

245

245

3,308

3,308

3,306

3,306

3,306

3,472

3,471

3,312

3,312

3,310

3,310

3,308

3,550

36,951

40,060

38,604

37,388

42,117

Accounts receivable, net of allowance for credit losses of $43 and $43, respectively

435

441

483

2,542

14,936

29,873

29,485

27,658

33,375

32,260

37,767

41,977

39,488

39,782

42,466

34,319

19,248

30,384

48,150

41,684

68,755

70,758

60,085

56,742

54,007

49,483

54,923

52,379

39,432

92,169

90,943

84,839

55,380

51,703

47,766

46,471

21,051

Other receivables

8,789

9,558

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other receivables

-

-

7,752

10,229

7,466

3,698

5,131

2,915

2,906

2,133

5,876

3,950

5,948

5,754

7,091

6,968

15,175

12,572

13,495

8,245

7,914

5,489

9,348

11,802

8,186

7,539

-

-

-

-

-

-

-

-

-

-

-

Inventory, Net

-

-

-

-

-

-

3,979

4,520

5,028

5,715

8,983

10,157

10,388

8,715

7,303

6,405

3,155

4,176

7,071

8,794

9,079

9,200

9,943

10,881

12,919

13,519

14,642

15,312

16,618

14,478

12,978

7,686

8,859

10,762

10,285

9,399

4,234

Prepaid expenses and other assets

10,263

10,148

12,680

10,839

7,955

7,574

8,300

4,769

3,803

10,067

2,957

4,369

3,726

3,930

2,702

2,954

2,352

3,507

3,963

2,688

3,375

3,774

4,505

3,410

17,697

3,213

4,852

7,149

3,126

2,745

3,853

1,800

2,303

2,074

571

883

906

Discontinued operations, current assets (Note 12)

-

-

0

0

0

5,555

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred tax assets

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

82

172

170

-

138

1,587

1,661

1,659

3,824

13,785

16,476

12,473

11,351

10,532

10,000

-

-

-

-

Total current assets

197,280

244,020

272,717

306,015

340,238

250,688

267,450

309,520

277,028

277,746

303,299

199,014

196,993

216,650

231,414

206,652

172,482

190,625

209,533

207,162

215,966

222,469

231,559

220,133

215,676

235,190

153,527

213,040

239,035

264,873

265,716

298,561

262,866

225,801

207,519

161,190

121,865

Investments

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

10,863

9,283

11,880

14,095

8,569

Property and equipment, net of accumulated depreciation

12,058

11,607

8,965

4,534

466

385

437

523

593

589

615

517

493

449

538

643

810

918

1,079

1,265

1,313

1,405

1,414

1,407

1,597

1,535

1,741

2,004

2,227

2,548

2,988

2,488

2,528

2,681

2,821

3,050

3,158

Intangible assets, net of accumulated amortization

-

-

-

-

-

-

116,273

123,214

130,319

137,159

144,036

150,815

157,419

164,234

171,460

178,312

184,753

190,335

201,184

207,955

214,606

230,100

237,244

219,735

225,591

231,352

236,626

203,017

206,593

200,234

204,633

60,327

40,231

41,654

43,078

43,962

29,605

Goodwill

-

-

-

-

-

-

18,091

18,106

18,227

18,162

18,131

18,057

17,917

17,886

18,017

17,997

18,044

17,960

18,023

17,995

17,949

18,195

18,295

18,476

18,496

18,501

7,900

28,940

28,904

7,279

29,976

2,389

-

-

-

-

-

Deferred tax assets

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

45,325

-

-

23,276

-

20,961

15,038

-

-

-

-

Other assets

3,187

4,000

8,613

8,277

8,180

7,188

10,376

13,159

18,106

53,783

35,736

26,684

30,684

29,549

28,015

25,600

25,304

19,211

17,842

19,952

18,808

17,864

21,156

15,197

13,621

12,577

8,614

13,568

9,369

6,745

6,228

2,846

2,355

1,361

576

379

434

Facility and equipment under lease

3,467

3,806

3,531

3,842

3,774

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Discontinued operations, non-current assets

-

-

0

0

0

132,625

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total assets

215,992

263,433

293,826

322,668

352,658

390,886

412,627

464,522

444,273

487,439

501,817

395,087

403,506

428,768

449,444

429,204

401,393

419,049

447,661

454,329

468,642

490,033

509,668

474,948

474,981

499,155

453,733

460,569

486,128

504,955

509,541

387,572

333,881

280,780

265,874

222,676

163,631

LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable and other accrued liabilities

49,130

54,284

39,959

44,455

60,302

81,312

57,633

49,886

50,927

58,117

49,635

55,617

48,228

52,483

49,977

48,208

47,503

56,539

79,264

71,823

82,153

84,994

101,801

69,178

71,414

79,837

71,320

85,249

82,653

105,252

93,289

89,610

56,618

54,771

50,054

56,539

38,704

Accrued payroll and benefits

4,568

7,686

6,475

5,262

5,168

9,853

7,744

4,946

3,401

9,261

7,636

6,244

5,174

8,981

7,741

6,496

4,555

8,188

7,140

5,777

4,378

8,444

6,863

5,149

4,408

6,872

-

-

-

4,835

-

-

-

-

-

-

-

Contract liabilities

-

-

1,360

7,245

4,850

4,850

0

0

0

3,872

2,783

2,551

2,922

3,188

4,458

3,461

1,312

6,130

9,990

7,087

17,045

9,959

1,090

33

458

156

1,068

2,000

3,000

12,300

12,300

12,300

12,300

12,300

12,300

12,300

12,300

Disposal Group, Including Discontinued Operation, Liabilities, Current

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accrued compensation and related expenses

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

7,771

4,363

3,720

-

15,057

3,505

3,021

1,788

3,638

2,816

3,313

Deferred development costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

3,251

3,251

803

-

700

-

-

-

-

-

-

Common stock warrant liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

10,391

3,904

FOLOTYN development liability

-

-

-

-

-

-

211

211

275

275

153

153

861

861

156

156

156

259

573

573

1,141

1,141

3,119

3,119

3,119

3,119

10,580

12,896

13,277

856

13,314

10,610

10,756

9,678

9,561

7,163

5,101

Revolving line of credit

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

25,000

50,000

75,000

75,000

75,000

-

-

-

-

-

-

Convertible senior notes

-

-

-

-

-

2,311

35,357

39,427

38,819

38,224

101,770

100,157

98,590

0

104,144

102,522

100,933

99,377

100,192

98,866

97,568

96,298

95,036

93,812

92,627

91,480

-

-

-

-

-

-

-

-

-

-

-

Acquisition-related contingent obligations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

6,000

5,227

5,373

5,243

5,091

4,901

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total current liabilities

53,698

61,970

47,794

56,962

70,320

98,326

100,945

94,470

93,422

109,749

60,207

64,565

57,185

65,513

62,332

58,321

59,526

76,343

102,340

90,503

109,808

109,439

112,873

77,479

79,399

89,984

93,990

107,759

103,453

123,243

134,660

116,025

82,695

78,537

75,553

89,209

63,322

FOLOTYN development liability, less current portion

-

-

-

-

-

-

11,905

11,980

12,008

12,111

12,273

12,410

11,910

12,269

14,004

14,227

14,354

14,427

13,827

13,916

13,978

14,644

13,283

14,069

14,387

14,623

-

-

-

11,377

-

-

-

-

-

-

-

Deferred revenue, less current portion

-

-

-

-

-

-

0

0

0

315

324

326

316

323

741

750

1,596

383

407

414

416

0

8,869

-

-

-

4,140

3,680

3,456

-

5,500

8,329

11,268

14,029

16,173

19,290

25,495

Capital lease obligations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

9

17

25

40

Convertible senior notes

-

-

-

-

-

-

-

-

-

-

-

-

-

97,043

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred development costs, less current portion

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

15,400

15,400

11,337

-

11,600

-

-

-

-

-

-

Deferred payment contingency

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2,374

2,287

2,200

-

-

-

-

-

-

Acquisition-related contingent obligations

-

-

-

-

-

-

5,555

6,755

6,563

6,272

4,551

1,609

1,512

1,315

1,915

1,993

1,708

1,439

2,534

2,745

2,751

2,441

10,239

10,058

9,053

8,329

-

-

-

-

-

-

-

-

-

-

-

Deferred tax liabilities, net

-

-

0

0

0

1,469

1,447

1,447

1,447

1,438

6,829

6,802

6,749

6,675

6,739

6,831

6,849

6,779

6,659

6,753

6,808

6,569

6,989

8,167

8,241

7,168

-

-

-

-

426

-

-

-

-

-

-

Tax liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

169

169

169

-

-

-

-

Other long-term liabilities

8,526

11,070

11,313

10,923

9,789

5,650

5,997

5,751

6,539

6,215

11,127

10,451

9,874

9,604

8,772

8,661

8,109

7,444

6,963

6,994

6,944

6,088

5,787

5,709

5,423

5,965

12,839

6,130

6,130

4,367

298

298

298

298

298

298

298

Discontinued operations, non-current liabilities

-

-

0

0

0

14,031

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total liabilities

62,224

73,040

59,107

67,885

80,109

119,476

125,849

120,403

119,979

136,100

197,081

196,320

186,136

192,742

198,647

193,305

193,075

206,192

232,922

220,191

238,273

235,479

253,076

209,294

209,130

217,549

151,369

182,969

201,750

216,274

229,853

124,821

94,430

92,873

92,041

108,822

89,155

Commitments and contingencies (Note 8)

-

-

-

-

-

-

0

0

0

-

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

-

-

0

0

0

0

-

0

0

0

Stockholders’ equity:
Preferred stock, $0.001 par value; 5,000,000 shares authorized; no shares issued and outstanding

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

-

0

0

0

-

0

0

-

0

0

-

-

-

-

0

-

Common stock, $0.001 par value; 300,000,000 shares authorized; 114,774,079 and 113,299,612 issued and outstanding at March 31, 2020 and December 31, 2019, respectively

114

113

113

112

111

110

106

103

103

100

94

80

80

80

80

75

68

68

66

66

66

66

66

66

65

64

64

60

60

60

60

60

60

59

57

53

51

Additional paid-in capital

923,480

918,205

912,558

905,871

895,571

886,740

840,681

829,052

820,701

837,347

765,754

646,542

642,518

648,384

638,006

606,220

555,056

552,108

548,232

545,359

541,157

538,553

535,645

532,554

529,745

518,144

499,783

468,653

465,373

463,710

466,655

463,607

458,011

452,761

446,804

404,273

384,757

Accumulated other comprehensive loss

-4,827

-3,498

-4,531

-3,764

-4,092

-3,702

-3,342

-3,088

-819

15,999

3,673

-1,779

380

-1,579

-2,090

-2,651

-3,485

-5,319

-3,712

-165

-2,077

-850

1,120

1,734

1,178

894

635

1,050

931

273

682

-525

-159

-227

-147

-176

-92

Accumulated deficit

-764,999

-724,427

-673,421

-647,436

-619,041

-611,738

-550,667

-481,948

-495,691

-502,107

-464,785

-446,076

-425,608

-410,859

-385,199

-367,745

-343,444

-334,123

-329,970

-311,245

-308,900

-283,338

-280,362

-268,823

-265,260

-237,619

-198,241

-192,286

-182,109

-175,485

-187,832

-197,271

-215,341

-261,883

-270,164

-290,419

-310,400

Less: Treasury stock at cost: 0 and 363,055 shares at December 31, 2012 and 2011, respectively

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

3,243

3,243

2,926

2,840

-

0

Total stockholders’ equity

153,768

190,393

234,719

254,783

272,549

271,410

286,778

344,119

324,294

351,339

304,736

198,767

217,370

236,026

250,797

235,899

208,318

212,857

214,739

234,138

230,369

254,554

256,592

265,654

265,851

281,606

302,364

277,600

284,378

288,681

279,688

262,751

239,451

187,907

173,833

113,854

74,476

Total liabilities and stockholders’ equity

215,992

263,433

293,826

322,668

352,658

390,886

412,627

464,522

444,273

487,439

501,817

395,087

403,506

428,768

449,444

429,204

401,393

419,049

447,661

454,329

468,642

490,033

509,668

474,948

474,981

499,155

453,733

460,569

486,128

504,955

509,541

387,572

333,881

280,780

265,874

222,676

163,631

Series E convertible voting preferred stock [Member]
Preferred stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

123

123

-

-

-

-

123

-

-

-